APA

Forsgård R. A., Marrachelli V. G., Lindén J., Frias R., Collado M. C., Korpela R., Monleon D., Spillmann T. & Österlund P. (2019). Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles. : Translational oncology.

Chicago

Forsgård Richard A, Marrachelli Vannina G, Lindén Jere, Frias Rafael, Collado Maria Carmen, Korpela Riitta, Monleon Daniel, Spillmann Thomas and Österlund Pia. 2019. Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles. : Translational oncology.

Harvard

Forsgård R. A., Marrachelli V. G., Lindén J., Frias R., Collado M. C., Korpela R., Monleon D., Spillmann T. and Österlund P. (2019). Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles. : Translational oncology.

MLA

Forsgård Richard A, Marrachelli Vannina G, Lindén Jere, Frias Rafael, Collado Maria Carmen, Korpela Riitta, Monleon Daniel, Spillmann Thomas and Österlund Pia. Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles. : Translational oncology. 2019.